Gts Securities LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $824,901 - $1.02 Million	2,100 Added 17.07%	14,400 $6.75 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $40,769 - $44,608	100 Added 0.82%	12,300 $5.14 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $3.16 Million - $3.78 Million	9,200 Added 306.67%	12,200 $4.96 Million
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $1.01 Million - $1.09 Million	3,000 New	3,000 $1.04 Million

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.